SCHEMBL16111138

SCHEMBL16111138

c1ccc(N2CCc3nc[nH]c3CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 2/20 0.45
AKT1 P31749 2/20 0.44
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
ADRB1 P08588 1/20 0.43
HTR3A P46098 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
IP6K1 Q92551 1/20 0.39
IP6K3 Q96PC2 1/20 0.39
HRH3 Q9Y5N1 2/20 0.38
HRH4 Q9H3N8 1/20 0.38
GRIN2B Q13224 1/20 0.38
KDM4B O94953 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
DRD2 P14416 1/20 0.38
NFKB1 P19838 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL550151 0.76 SIGMAR1 (0.50) ADRA1ALMNAMAPTSIGMAR1HRH3
SCHEMBL12082637 0.73 AKT1 (0.39) ADRA1AAKT1HTR3EHTR3BHTR3A
SCHEMBL13999400 0.69 HRH3 (0.43) ADRA1AAKT1LMNAHTR3EHTR3B
SCHEMBL22915965 0.69 ACHE (0.50) MAPTSIGMAR1HRH3DRD2NPC1
SCHEMBL22915890 0.67 KDM4E (0.47) SIGMAR1HPGD
SCHEMBL22915978 0.67 HRH3 (0.47) SIGMAR1HRH3DRD2
SCHEMBL550173 0.66 ADRA1A (0.40) ADRA1AAKT1LMNAHTR3AHRH3
SCHEMBL385012 0.66
SCHEMBL164538 0.66 LMNA (0.67) LMNAMAPTHTR3EHTR3BADRB1
SCHEMBL576454 0.66 LMNA (0.67) LMNAMAPTHTR3EHTR3BADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2978763-A1 2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS Bristol-Myers Squibb Company (US) 2016-02-03 EP disclosed
WO-2014160692-A1 2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-10-02 WO disclosed